EUVIMEDEUVIMED entdecken
Fallbericht

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis

Andreas Reiter, Julien Rossignol, Michael W Deininger, Johannes Luebke, Olivier Hermine, Cem Akin, Jason Gotlib, Deepti H Radia

The Journal of Allergy and Clinical Immunology: In Practice · 2026

DOI: 10.1016/j.jaip.2025.10.034 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Andreas Reiter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. Electronic address: andreas.reiter@med…. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Proto-Oncogene Proteins c-kit. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Cogent Biosciences, Wilhelm Sander-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic mastocytosis (SM) is a rare hematological neoplasm driven by the KIT D816V mutation in up to 95% of cases. SM is classified into nonadvanced SM-comprising indolent SM (ISM), bone marrow (BM) mastocytosis, and smoldering SM-and advanced SM (AdvSM), with the subtypes aggressive SM, SM with an associated hematological neoplasm (SM-AHN according to the World Health Organization), and mast cell (MC) leukemia. Clinical presentations are heterogeneous, and careful evaluation of clinical and laboratory parameters is required to plan patient management. Here we discuss the diagnosis and treatment of 2 patients with KIT D816V positive SM, 1 with AdvSM and 1 with ISM, both of whom received KIT-targeted therapies. In addition to clinical presentations caused by a combination of MC mediator symptoms and consequences from MC infiltration of different organ systems, the diagnostic workup included qualitative and quantitative assessment of variably affected key parameters from (1) peripheral blood (eg, blood counts, serum tryptase, and other serum markers; variant allele frequency [VAF] of KIT D816V; and additional somatic mutations); (2) BM MC infiltration, KIT D816V VAF, presence/absence of an AHN/associated myeloid neoplasm, and cytogenetic analysis; and (3) organ infiltration/dysfunction (primarily affecting skin, bone/BM, and visceral organs).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastocytosis, SystemicProto-Oncogene Proteins c-kitHumansMast CellsMutation

Stichwörter der Autor:innen

AvapritinibKIT inhibitorMidostaurinSystemic mastocytosis

Substanzen

KIT protein, humanProto-Oncogene Proteins c-kit

Autor:innen und Institutionen

  • Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. Electronic address: andreas.reiter@medma.uni-heidelberg.de.
  • French Reference Center for Mastocytosis (CEREMAST), Paris Cité University, Necker-Enfants Malades University Hospital, AP-HP, Paris, France.
  • Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, Wis.
  • Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich.
  • Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, Calif.

Förderung

  • Cogent Biosciences
  • Wilhelm Sander-Stiftung

Zitieren

APA

Reiter, A., Rossignol, J., Deininger, M. W., Luebke, J., Hermine, O., Akin, C., Gotlib, J., & Radia, D. H. (2026). KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.10.034

Vancouver

Reiter A, Rossignol J, Deininger MW, Luebke J, Hermine O, Akin C, et al. KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2025.10.034

BibTeX
@article{Reiter2026,
  author = {Reiter, Andreas and Rossignol, Julien and Deininger, Michael W and Luebke, Johannes and Hermine, Olivier and Akin, Cem and Gotlib, Jason and Radia, Deepti H},
  title = {KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  doi = {10.1016/j.jaip.2025.10.034}
}
Kostenlos starten →